Peter Laird Archives

April 5, 2018 Van Andel Research Institute scientists help redefine how cancer is categorized

GRAND RAPIDS, Mich. (April 5, 2018) — Van Andel Research Institute (VARI) announced today that the work of its scientists is featured in 27…

April 2, 2018 Scientists discover new method for measuring cellular age
Nature Genetics paper shows cells begin losing important DNA marks in utero

GRAND RAPIDS, Mich., and LOS ANGELES (April 2, 2018) — A team led by scientists at Van Andel Research Institute (VARI) and

June 21, 2017 Research brief: Developing a “roadmap” for the second deadliest cancer worldwide

Epigenetics: Refers to the packaging and marking of DNA, which guides whether genes are on or off and to what extent. Epigenetic errors can lead to…

March 14, 2017 Research brief: Four molecular subtypes revealed in rare bile duct cancer

The short version Scientists now have a new resource for studying a rare bile duct cancer that may serve as a blueprint for placing patients…

January 4, 2017 Comprehensive study of esophageal cancer reveals several molecular subtypes, provides new insight into increasingly prevalent disease

The Cancer Genome Atlas Research Network recommends clinical trials organizers and drug manufacturers focus on newly discovered molecular subtypes GRAND RAPIDS, Mich. (Jan. 4, 2017) –…

November 17, 2016 Van Andel Research Institute, Cedars-Sinai awarded National Cancer Institute grant for epigenomic data analysis

GRAND RAPIDS, Mich. (Nov. 17, 2016)—Van Andel Research Institute (VARI), in collaboration with Cedars-Sinai, has received a $2.5 million, five-year grant from the National Cancer…

November 5, 2015 TCGA findings provide molecular background for second most common kidney cancer

GRAND RAPIDS, Mich. (Nov. 5, 2015)—Scientists with The Cancer Genome Atlas (TCGA), a National Institutes of Health-funded project, have…